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Cryo-EM analysis of homodimeric 
full-length LRRK2 and LRRK1 
protein complexes
Kushal Sejwal1, Mohamed Chami1, Hervé Rémigy2, Renée Vancraenenbroeck3,5, William 
Sibran4, Rosmarie Sütterlin1, Paul Baumgartner1, Robert McLeod1, Marie-Christine Chartier-
Harlin4, Veerle Baekelandt3, Henning Stahlberg1 & Jean-Marc Taymans  3,4
Leucine-rich repeat kinase 2 (LRRK2) is a large multidomain protein implicated in the pathogenesis 
of both familial and sporadic Parkinson’s disease (PD), and currently one of the most promising 
therapeutic targets for drug design in Parkinson’s disease. In contrast, LRRK1, the closest homologue 
to LRRK2, does not play any role in PD. Here, we use cryo-electron microscopy (cryo-EM) and single 
particle analysis to gain structural insight into the full-length dimeric structures of LRRK2 and LRRK1. 
Differential scanning fluorimetry-based screening of purification buffers showed that elution of the 
purified LRRK2 protein in a high pH buffer is beneficial in obtaining high quality cryo-EM images. Next, 
analysis of the 3D maps generated from the cryo-EM data show 16 and 25 Å resolution structures of 
full length LRRK2 and LRRK1, respectively, revealing the overall shape of the dimers with two-fold 
symmetric orientations of the protomers that is closely similar between the two proteins. These results 
suggest that dimerization mechanisms of both LRRKs are closely related and hence that specificities 
in functions of each LRRK are likely derived from LRRK2 and LRRK1’s other biochemical functions. To 
our knowledge, this study is the first to provide 3D structural insights in LRRK2 and LRRK1 dimers in 
parallel.
Parkinson’s disease (PD) is the second most common neurodegenerative movement disorder. It affects 1–2% 
of all people above the age of 651 and is at present incurable, although treatments are available to alleviate the 
symptoms. Genetic studies have identified several genes involved in PD pathogenesis. The leucine rich repeat 
kinase 2 (LRRK2) gene is of particular importance, with mutations in the coding sequence being the most prev-
alent known causes of genetic PD and genomic variants at the LRRK2 locus being common risk factors for spo-
radic PD2. In addition, LRRK2 appears to act upstream of several other PD genes and PD risk factors, such as 
alpha-synuclein, tau, cyclin G associated kinase (GAK) and RAB7L13, 4. The 144 kb-long LRRK2 gene encodes 
for the 2527 amino acids long, cytosolic enzyme LRRK2, which functions as a GTPase as well as a kinase. Most 
of the pathologically important mutations are clustered in the catalytic core of this protein, hinting that altered 
GTPase and kinase activities may play a crucial role in pathogenesis5, 6. Targeting the LRRK2 signaling pathway is 
currently regarded as one of the most promising approaches in drug development for PD7–10.
LRRK2 is a member of the ROCO protein family11. It contains several protein-protein interaction domains, 
including armadillo (ARM), ankyrin repeats (ANK), leucine-rich repeats (LRR), Ras Of Complex proteins 
GTPase (ROC), C-terminal Of ROC (COR), a kinase (KIN) and WD4012 (Fig. 1). The multidomain protein 
is involved in several cellular functions, including autophagy and neurite outgrowth regulation, and is related 
to some mitochondrial diseases13–15. Biochemical experiments suggest that the kinase and GTPase activities of 
LRRK2 are regulated by dimerization16–19.
Three other ROCO proteins have been identified in humans: Leucine-rich repeat kinase 1 (LRRK1), 
death-associated kinase 1 (DAPK1), and malignant fibrous histiocytoma amplified sequence 1 (MFASHI1). 
LRRK1 is the closest homologue of LRRK2. The domain organization is similar and, like LRRK2, LRRK1 is 
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known to purify as homodimer20. LRRK1 (2015 amino-acids long) lacks the ARM domain present in LRRK2 
and, although a C-terminal kinase region is present, has no WD40 domain. Otherwise, the sequence identity and 
similarity between the domains of the two proteins varies between 14% and 50% (Fig. 1, and supplemental data). 
Despite this similarity, mutations in LRRK1 have not been linked to PD. This difference has stimulated various 
studies comparing the functional roles of LRRK1 and LRRK221–23.
Much available structural knowledge about LRRK2 comes from the study of related ROCO proteins from 
lower organisms. So far, crystal structures have been published for the ROC (PDB ID code 3DPT) and ROC-COR 
(PDB ID code 3DPU) domains of the ROCO protein of the thermophilic bacterium Chlorobium tepidum and 
the kinase domain (PDB ID code 4F0F) of the ROCO4 protein of the slime mold Dictyostelium discoideum24–26. 
Although, these structures have advanced our understanding of LRRK2 functions, the inferred functionality of 
the full-length protein is indirect. The structural properties of individual human LRRK2 domains have also been 
studied, including the ROC (PDB ID code 2ZEJ)24 and the LRR27 domains. Recently, a low-resolution structure 
of the 3-flag tagged wild-type LRRK2 dimer was obtained by negative stain transmission electron microscopy 
(TEM), indicating a compact architecture28. Structural information on LRRK1 is minimal; no 3D structures have 
been reported, for the full-length protein or fragments thereof.
In this study, we report a buffer optimization for LRRK2 and LRRK1 protein production, using ProteoPlex. 
ProteoPlex is a screening method based on the Thermofluor® differential scanning fluorimetry assay and can 
be used to assess the stability of multidomain macromolecular protein complexes in a given buffer system. 
ProteoPlex uses sparse-matrix screening of a protein’s thermal unfolding behavior under various conditions to 
find the optimum buffer conditions favoring stable and monodisperse complexes29. Similar methods based on dif-
ferential scanning fluorimetry (DSF) are routinely employed in X-ray crystallography to optimize the quality and 
quantity of protein samples for further crystal screening30, but so far have rarely been employed in combination 
with cryo-electron microscopy (cryo-EM) studies.
In this study, we also report the 16 Å and 25 Å resolution 3D structures of the homodimeric full-length 
3xflag-LRRK2 and 3xflag-LRRK1 complexes respectively, determined by cryo-EM. The use of TEM to evaluate 
protein quality and buffer optimization using differential scanning fluorimetry enabled the optimization of the 
LRRK protein purifications for the cryo-EM analysis. Both, the 2D analysis of LRRK2 and LRRK1 images, and 
their 3D models, reveal a striking similarity between the tertiary and quaternary structure of the two protein 
dimers.
Results
Detergent is required for LRRK2 to remain correctly folded. The production of protein in high yield 
and purity is a prerequisite for structural analysis by cryo-EM31, 32. Pooling the cell lysate from several Petri dishes 
and eluting the protein in less volume (see Materials and Methods) resulted in protein concentrations as high as 
1 mg/ml for both LRRK2 and LRRK1, regardless of the buffer system used (see below). This concentration was 
sufficient for initial negative stain TEM imaging, and for cryo-EM if the Quantifoil grids employed were coated 
with an additional carbon film. Ultra-centrifugal filter devices could not be used to concentrate either protein, 
because both tended to precipitate and bind to the filter membrane (data not shown).
We evaluated the possibility to perform EM analysis of recombinant LRRK2 in the absence of detergent. For 
this, purifications of 3xflag-LRRK2 were carried out as detailed in Section 2.1.3, including lysis and wash steps 
with buffers containing detergent, but with omission of detergent in the final rinse and elution steps. Under these 
conditions, negative stain TEM of the protein preparations revealed globular particles of various sizes that had no 
recognizable structure (Fig. 2A). In contrast, a small population of elongated particles with features was observed 
when 0.02% (v/v) Triton X-100 was included in the elution buffer (Fig. 2B). Protein stability did not increase fur-
ther when other nonionic detergents were tested; the purity and quality of the eluted protein remained the same, 
when Triton X-100 was replaced by 0.02% (v/v) n-decyl-β-D-maltopyranoside (DM), NP-30, lauryl maltose neo-
pentyl glycol (LMNG) or Tween 20 (data not shown). Consequently, 0.02% (v/v) Triton X-100 was included in all 
buffers used to elute 3xflag-LRRK2 and 3xflag-LRRK1 for EM experiments.
Silver stain gels showed that the purified LRRK2 and LRRK1 samples were pure (Fig. 3). However, images of 
purified LRRK2 showed a very heterogeneous mixture, even though detergent was present (Fig. 4A, left panel). 
Figure 1. Domain organisation of LRRK2 and LRRK1. LRRK2 and LRRK1 domains are depicted with different 
colors and their relative location is drawn to scale within the full-length protein: ARM, armadillo repeats; ANK, 
ankyrin repeats; LRR, leucine-rich repeats; ROC, Ras Of Complex proteins GTPase; COR, C-terminal Of ROC; 
KIN, a kinase; WD40, WD40 repeats. The sequence identity and sequence similarity is reported in the column 
with same color below each domain (adapted from ref. 20). A detailed alignment between the human LRRK2 
and LRRK1 sequences for each homologous domain is given in the supplemental data.
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Compared to LRRK2, negative stain TEM images of pure LRRK1 were slightly less heterogeneous and revealed 
a large population of similarly sized particles (Fig. 4B). This prompted us to perform buffer optimization experi-
ments, in order to identify buffers that reduce particle heterogeneity.
Buffer optimization by ProteoPlex screening. Three ProteoPlex assays29 were performed to define 
(i) the optimal buffer conditions and (ii) the effect of buffer ligands/additives for the stability of affinity-bound 
3xflag-LRRK2 protein, which correlates to the optimal lysis/binding buffer for the purification and (iii) the opti-
mal buffer conditions for the elution of affinity-bound 3xflag-LRRK2. For assay (i), purified protein loaded to 
affinity resin was prepared and submitted to ProteoPlex analysis as described in Materials and Methods. In assay 
(i), substantial peaks indicating protein unfolding or aggregation were detected with many buffers in the tem-
perature range between 20 and 40 °C. Hepes at pH 6.8 proved to be the most favorable buffer (Supplementary 
Figure S1). In assay (ii), subsequent screening of 88 different buffer ligands/additives with 3xflag-LRRK2 purified 
with lysis, wash and rinse buffers in which Tris pH 7.5 was replaced by Hepes at pH 6.8 and still bound to the 
affinity beads. Screen (ii) showed that CaCl2, MgCl2, NH4Cl, gluthathion (oxidized and reduced), ethylene glycol, 
trehalose, and glycerol had a stabilizing effect on the protein (Supplementary Figure S2). As a result, subsequent 
Figure 2. Effect of detergent on the 3xflag-LRRK2 structure. Negative stain TEM images of LRRK2 eluted using 
in 20 mM Tris/HCl pH 7.4, 200 mM NaCl, 5 mM MgCl2, 1 mM DTT. (A) Without the addition of detergent; 
almost all of the particles have a globular appearance and structural details are not visible. (B) With 0.02% of 
Triton X-100; many of the particles have an elongated shape and some structural detail is evident. Dimeric 
sides-views are clearly visible (inset). However, there are also some globular particles demonstrating that even 
in the presence of detergent the protein is not completely stable when the Tris buffer is employed (see Materials 
and Methods and Fig. 4). Scale bars: 100 nm. Insets are 5 times magnified.
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purifications were carried out using the adapted buffer system, 20 mM Hepes pH 6.8, 10 mM CaCl2, 5 mM MgCl2, 
100 mM NH4Cl, 1% (v/v) Triton X-100, 5% (v/v) glycerol. Protein purified with this buffer for the lysis and wash 
steps was used in assay (iii) performed to find the best elution conditions. As described in Materials and Methods, 
the affinity bound protein was first rinsed in test elution buffers (effectively removing Triton X-100 and glycerol). 
In this elution buffer screen, Hepes at pH 8.2 was the most favorable buffer (Supplementary Figure S3). Therefore, 
we adapted the elution buffer composition for 3xflag-LRRK2 to 20 mM Hepes pH 8.2, 100 mM NH4Cl, 5 mM 
MgCl2, 10 mM CaCl2, and 0.02% Triton X-100.
The overall result of the ProteoPlex assays is summarized in Fig. 4C, where the melting curves of 3xflag-LRRK2 
in the initial (based on Tris pH 7.5, see Materials and Methods) and adapted buffer systems (based in Hepes 6.8 
in the lysis and wash buffers and Hepes 8.2 in the elution buffer, see above) are superimposed showing the clear 
two-state melting curve for the adapted condition. Although, the yield of a new LRRK2 purification carried out 
using the adapted buffers, HEPES buffer at pH 6.8, for cell lysis and protein extraction by affinity binding, and 
HEPES buffer at pH 8.2 to elute it from the affinity column, was comparable to the yield of control purifications 
carried out under the initial conditions with Tris/HCl buffers, the sample was of higher quality. Indeed, nega-
tive stain TEM images revealed a larger population of intact complexes, and the background was much cleaner 
with fewer aggregates (Fig. 4A, right). These adapted purification conditions were, therefore used to purify 
3xflag-LRRK2 for cryo-EM analysis.
Cryo-EM of LRRK2. 3xflag-LRRK2 protein purified with optimized lysis, wash and elution buffers (see 
above) was applied to glow-discharged thin (5 nm) carbon films supported by holy carbon Quantifoil grids, vitri-
fied and imaged as described in Materials and Methods. A thin carbon support film was essential, even though it 
can influence protein orientation, add additional noise and impair CTF correction. In its absence, proteins were 
only present on the thick carbon mesh, none were found in the vitreous ice spanning the holes; neither increasing 
the protein concentration tenfold, nor using Lacey grids, which have mesh-like openings of different sizes and 
shapes, helped (Supplementary Figure S4).
Elongated particles with two-fold symmetry could be distinguished in the raw micrographs of 3-flag-LRRK2 
cryo-EM preparations (Fig. 5A). To obtain a 3D model, 15′352 particles were selected from the 279 micrographs 
recorded and subjected to reference free alignment and classification as detailed in the Materials and Methods. 
The 128 class averages generated (Supplementary Figure S5A) show that the LRRK2 complexes were randomly 
oriented on the grid and reveal a high degree of flexibility; preferential orientation due to the presence of a con-
tinuous carbon film was not detected. Side-views of the particles are very characteristic, being ~17 nm-long, 
~10 nm-wide with a clear 2-fold symmetry, suggesting that the complex is a dimer (Fig. 5A). The dimensions 
are similar to previous estimates20. The two 3-flag-LRRK2 monomers interact at both ends of their protein cores, 
which are aligned in parallel and seem to form a small cavity. The ends of the complex are less distinct, indicating 
that these domains have intrinsic flexibility. To validate the analysis, the same dataset was also processed with 
the RELION software package33, which uses a Bayesian approach to infer the parameters of a statistical model 
Figure 3. Expression and purification of full-length 3xflag-LRRK2 and 3xflag-LRRK1. (A) Silver stained gel 
of 3xflag-LRRK2 and 3xflag-LRRK1 purified as described in Materials and Methods. In both cases, the protein 
concentration was 10 μg/ml and a 10 μl aliquot was added to the gel. The dominant bands observed at the 
molecular weights 215 and 285 kDa are 3xflag-LRRK2 and 3xflag-LRRK1, respectively, indicating highly pure 
protein fractions. Markers are in kiloDaltons. (B) Functionality of the purified 3xFlag-LRRK1 and 3xFlag-
LRRK2 proteins was assessed using a radiometric GTP binding assay as described in materials and methods. 
Proteins were incubated at 30 °C with GTP-α-P32 alone or with addition of 200 mM ‘cold’ nucleotides. After 
incubation, excess nucleotides were rinsed away and the amount of bound isotopic GTP was measured via 
scintillation counting and expressed as binding level relative to control protein (n = 3).
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from the data. The resulting class averages are very similar to those obtained using EMAN2 (Supplementary 
Figure S5B).
Cryo-EM of LRRK1. 3xflag-LRRK1 protein purified as described in Materials and Methods was analyzed 
according to the same procedure. To obtain a 3D model, 5′363 particles were selected from 55 micrographs, 
aligned without the use of a reference and classified into 64 classes containing a minimum of 100 particles each, 
using EMAN2 (Fig. 5B). Due to the lower number of particles per class, the averages obtained look less crisp as 
their LRRK2 counterparts, but the characteristic side-views are clearly visible (Fig. 5B). These side views show 
Figure 4. Negative stain TEM of 3xflag-LRRK2 and 3xflag-LRRK1 and buffer optimization for 3xflag-LRRK2 
by ProteoPlex screening. (A) (Left) Negative stain TEM micrograph of LRRK2 purified in binding buffer at pH 
7.5 and eluted in elution buffer Tris/HCl at pH 7.4 after a wash step. The sample is heterogeneous with many 
disintegrated protein particles in the background and some aggregates. (Right) Negative stain TEM micrograph 
of the LRRK2 sample purified in binding buffer at pH 6.8 and eluted in elution buffer at pH 8.2 as suggested 
by ProteoPlex screening. Although there is still some heterogeneity, more particles are intact (arrows) and the 
background is much cleaner. Scale bars: 100 nm. (B) Negative stain TEM micrograph of LRRK1 purified as 
described in Materials and Methods with Tris/HCl based binding buffer at pH 7.5 and eluted in Tris/HCl based 
elution buffer at pH 7.4. Distinct dimeric LRRK1 particles can be clearly seen (arrows) with few aggregates and 
smaller particles in the background. Scale bars: 100 nm. (C) ProteoPlex melting curve profiles obtained for 
LRRK2 eluted in Tris pH7.4 and Hepes pH8.2. Relative fluorescent intensity is plotted for the temperature range 
of 20°–100 °C. The standard ProteoPlex algorithm could not be used to calculate a thermodynamic model, as 
the fluorescence signal was too low. Trend lines were calculated using a moving average with a period of 2. The 
melting curve displays already aggregation at 20 °C when a Tris pH 7.4 buffer was used to elute LRRK2, whereas 
a peak occurs at 25 °C and the curves displays a 2-state unfolding between 20 and 40 °C when the elution was 
performed with Hepes 8.2, indicating that this buffer places the LRRK2 protein in more favorable conditions, 
i.e., predictive of stable and monodisperse protein complexes. This latter buffer was then used as the basis for 
LRRK2 elution in subsequent preparations of LRRK2 protein for cryo-EM. Additional melting curve profiles for 
the buffer screens (binding buffer and elution buffer screens) are given in Supplementary Figures S1, S2 and S3.
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that LRRK1 forms a dimer that is very similar to the LRRK2 dimer, but slightly smaller. As might be expected 
from the two sequences (Fig. 1), the protrusions at the ends of the LRRK1 complex are less prominent.
3D Reconstruction of LRRK2 and LRRK1. The initial 3D models generated for both LRRK2 and LRRK1 
using spacegroups C1 (no symmetry) and C2 (two-fold symmetry), respectively, were in good agreement, which 
was also evident from the dimeric shape of the 2D class averages (Fig. 5). Using the respective initial model as 
reference, iterative projection-matching reconstruction was applied without imposing any symmetry. After three 
rounds of refinement, the final reconstruction was produced at a resolution of 24.2 Å and 24.3 Å for 3xflag-LRRK2 
and 3xflag-LRRK1, respectively (Supplementary Figure S6).
The overall shape of the LRRK2 and LRRK1 complexes is similar (Fig. 6). In both cases, the central regions of 
the two monomers form an elliptical homodimer with what appears to be a central cavity (Fig. 6C). However, as 
this region of the monomer is slightly more curved for the LRRK2 dimer, the cavity is smaller. Two dimerization 
contacts are visible in both low-resolution maps. These contacts are at roughly equal distances from the center of 
the complex, towards the N and the C terminal, respectively. At this resolution, it was not possible to assign and 
fit domains to the EM density. However, the two-fold symmetric arrangement of the two monomers is evident in 
the non-symmetrized reconstructions, and the symmetry axis of the C2 symmetric complex is in the direction 
of the longer axis of the molecule, which is vertical in Figs 6 and 7. This symmetry axis is also apparent in the 2D 
class averages, shown in Fig. 5. The 3D reconstructions also show the central protein region, which is common to 
Figure 5. Cryo-EM and single particle processing of 3xflag-LRRK2 and 3xflag-LRRK1. (A) LRRK2 complexes 
eluted in Hepes buffer at pH 8.2, imaged by cryo-EM. Right: Selected EMAN2 class averages showing 
characteristic side-views of the complex. Particles in this view are ~17 nm long and ~12 nm wide. Their two-
fold symmetry indicates that the complex is a dimer. (B) LRRK1 complexes eluted in Tris buffer at pH 7.4, 
imaged by cryo-EM. Right: Selected EMAN2 class averages showing characteristic side-views of the LRRK1 
complex. These are very similar to corresponding side-views of LRRK2 but slightly smaller, being ~16 nm long 
and ~10 nm wide. The dimeric arrangement is apparent. Scale bars: 100 nm for the micrographs, 10 nm for the 
averages.
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Figure 6. 3D reconstructions of the homodimeric 3xflag-LRRK2 and 3xflag-LRRK1 complexes. (A) 3D model 
of 3xflag-LRRK2 (red) at 24.2 Å resolution showing the side-view orientations, the lower one being 90 degrees 
rotated relative to the upper one. (B) 3D model of 3xflag-LRRK1 (blue) at 24.3 Å resolution showing two side-
view orientations, the lower one being 90 degrees rotated relative to the upper one. (C) Cut-away of 3xflag-
LRRK2 (red) and 3xflag-LRRK1 (blue). The plane of the slice is perpendicular to the presumed dimer axis. Scale 
bars: 10 nm.
Figure 7. 3D reconstruction of the homodimeric LRRK2. 3D model of LRRK2 at 16.2 Å resolution showing the 
side-view orientations, the right one being 90 degrees rotated relative to the center one. The left is a cut-away of 
LRRK2 with the plane of the slice. Also shown are the dimerisation axis between the LRRK2 monomers (green 
dot and dashed green line). In the left and the central panel, the dimerization axis points towards the reader. In 
the right panel, it points form left to right along the middle of the molecule. The label for N-Terminal armadillo 
repeats domain, ARM are depicted in the left panel. The ARM domain here is visible only in the front, due to the 
perspective display that hides the rear ARM domain behind the molecule.
www.nature.com/scientificreports/
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both LRRK2 and LRRK1, to form a small cavity in the dimer. We tentatively interpret this region as the catalytic 
core of the complex comprised of the ROC-COR-kinase domains found in both proteins.
To increase the resolution and address conformational heterogeneity in the data, a bigger dataset for LRRK2 
was recorded by cryo-EM. A total of 279 micrographs of LRRK2 were collected which yielded a total of 15′352 
particles, out of which only 8′239 particles were retained after 2D classification in RELION. These particles were 
used to perform 3D classification in RELION using four classes with C2 symmetry. The resulting 3D structures of 
four classes were similar with roughly equal number of particles. The best class, which represented 27.2% of the 
total particles, resulted in an EM density map at 16.2 Å resolution (Fig. 7). The resolution was calculated based on 
the spectral signal-to-noise ratio curve (SSNR) (Supplementary Figure S7). Via this higher resolution EM density 
map, the 3D model of LRRK2 revealed an antiparallel arrangement of the LRRK2 protomers in the homodimer 
as well as information on which domains interact which each other. The extra density protruding from each trans 
end of the dimer can be attributed to the N-terminal ARM domain while the WD40 domain is likely associated 
with either ANK or LRR domain to form a dimer. Based on our EM model, we propose a model for the domain 
arrangement of LRRK2 and LRRK1, showing antiparallel dimers with suggested domains extending beyond the 
dimer core (Fig. 8).
Discussion
The determination of the full-length structure of both LRRK2 and LRRK1 is an important goal to further our 
understanding of the molecular mechanisms underpinning functions of LRRK proteins. Also, given that LRRK2 
is a key player in the pathogenesis of Parkinson’s disease while LRRK1 is not, the comparison of structures of both 
LRRK proteins may yield clues to LRRK2’s pathological functions and aid in designing novel LRRK2 targeting 
therapeutics. Our study worked on two aspects, the improvement of protein quality for structural analysis and 
performing single particle analysis cryo-EM. Buffer screening and calculating associated thermal shift assays 
using ProteoPlex revealed that LRRK2 favors a higher pH to be stably and correctly folded in solution. It should 
be noted that the pH of most of negative stain used routinely in EM for structural analysis is either acidic or neu-
tral, e.g., uranyl formate is acidic with a pH ~ 434. Although it has been shown that the fixation rate is very rapid 
and the low pH usually does not affect the overall protein conformations, a possible effect of the acidic stain on 
the protein state cannot be ruled out completely, especially for pH-sensitive protein complexes. As observed in 
comparing Figs 4 and 5, the raw LRRK2 and LRRK1 particles in negative stain micrographs displayed a different 
visual aspect compared to the cryo-EM micrographs, owing to low pH exerted by negative stain on LRRKs.
Taking into account the potential effect of negative staining on the LRRK structures, we used unstained 
cryo-EM to collect structural data for LRRK2 and LRRK1. The generated 3D maps show full-length 16 and 25 Å 
resolution structures of LRRK2 and LRRK1, respectively, revealing the overall shape of the dimers that is closely 
similar between the two proteins. Our study presents the first 3D of the full-length human LRRK1 dimer struc-
ture and provides additional structural details to the recent report of the LRRK2 dimer structure based on a 
negative stain EM28. Comparing the structure reported in Guaitoli et al.28 with the LRRK2 structure presented 
here, both structures show dimer particles of similar size, and both dimers show tightly packed domains with 
dimerization occurring over a single twofold rotation axis. Also, both structures are compatible with a model in 
which the LRRK2 ARM domain extends outside of the LRRK2 dimer core (Figs 6 and 7), a finding corroborated 
by the low level of cross-linking observed between the ARM domain and other LRRK2 domains28. In contrast, 
the slightly higher resolution LRRK2 structure in our study (16 Å in Fig. 7 vs. 22 Å in ref. 28) reveals additional 
details, in particular that the homodimer protomers are arranged in two-fold symmetric orientation forming 
an elongated cavity, and that the ARM domain curves away from the dimer core instead of extending along the 
dimer axis. As noted above, these discrepancies may be due to the use of a buffer specifically optimized here for 
structural biology analysis of LRRK2 in solution, the use of the cryo-EM technique that maintains complexes in 
a 3D matrix rather than 2D matrix for negative stain techniques and/or the improved resolution of the structure 
obtained in the present study.
Figure 8. A model for the antiparallel arrangement of protomers in the LRRK2 and LRRK1 dimers. Depicted 
are the proposed overall orientations of the LRRK2 and LRRK1 dimers as derived from the models calculated 
from cryo-EM experiments, showing antiparallel orientation of LRRK2 and LRRK1 protomers in their 
respective dimers, as well as the extension of the N-terminal domain outside of the antiparallel dimer.
www.nature.com/scientificreports/
9ScieNTific REPoRTS | 7: 8667  | DOI:10.1038/s41598-017-09126-z
At the resolutions obtained here for the LRRK2 and LRRK1 structures, fitting of domains in the EM den-
sity maps is not possible. However the arrangement of the protomers in the LRRK2 and LRRK1 dimers can be 
inferred indirectly. The protomers in both the complexes arrange in a two-fold symmetric orientation where the 
C-terminal kinase and WD40 domains of one protomer interact with N-terminal ankyrin and LRR domains of 
the other. The symmetric orientation of the LRRK2 protomers is consistent with other observations including 
that LRRK2 autophosphorylates itself primarily in the ROC domain. Indeed, the ROC domain of one protomer 
would in this instance be accessible to the kinase domain of the second protomer, although intramolecular ROC 
phosphorylation is not excluded17. Interestingly, the cavity formed within the dimer provides additional space 
for flexibility of the LRRK proteins and may play a role in dynamic interactions between functional domains. 
Another feature of the LRRK2 and LRRK1 models is that large surface areas of the proteins remain available for 
further interactions. For instance, binding interfaces of specific domains are known to be mapped to specific 
domains such as p21-activated kinase 6 (PAK6) and tubulin to ROC, heat shock protein 90 (HSP90) to Kinase, or 
N-ethylmaleimide sensitive fusion (NSF) to WD4035–38.
Interestingly, the striking similarity on the overall structures of LRRK2 and LRRK1 suggests that the specificity 
of LRRK2 versus LRRK1 in its role in Parkinson’s disease must be sought at another level. A first hypothesis is that 
LRRK2’s specificity is largely mediated by its N-terminal domain that is shown here to be located on the fringe 
of the LRRK2 dimer core (Figs 6 and 7 and ref. 28). Alternatively, structural subtleties may be present within 
the respective dimer cores of LRRK2 and LRRK1 responsible for differences in the regulation of its biochemical 
functions or of its protein-protein interactions. Finally, based on the high structural variability observed here, it 
should be noted that the LRRK2 and LRRK1 models presented constitute only one of several conformations of 
these proteins. Several studies have for instance suggested that dimerization may influence the GTPase and kinase 
functions39, indicating that different dimer conformations may lie at the basis of these functional differences.
The work presented here lays the foundations for further exploration into LRRK structural biology. For 
instance, a major question is whether the overall LRRK2 structure is affected by disease-causing mutations. At 
the biochemical level, several studies have reported that LRRK2 disease mutations, particularly mutations in the 
ROC and COR domains, can affect dimerization16, 17, 40. Work in this area has also shown that disease mutations 
can affect interactions between LRRK2 domains without affecting overall dimerization, suggesting that the overall 
dimer structure is likely to be affected16, 40. Another issue to address at the structural level is the intramolecular 
regulation of LRRK2 functions. For instance, LRRK2 kinase activity requires the LRRK2 ROC domain but is not 
dependent on ROC’s GTP binding activity per se41. In addition, it is as yet unclear what effect LRRK2 autophos-
phorylation has on LRRK2 function. While autophosphorylation is not easily detected in vivo, at least 1 phos-
phorylation site S1292 is found with increased phosphorylation levels in cellular and animal models based on the 
LRRK2 mutant G2019S. In addition, phosphorylation of this site is increased in urinary exosomes of both LRRK2 
G2019S carrying and sporadic PD patients42.
In conclusion, we present a comparative cryo-EM-based insight into the 3D structures of full length LRRK2 
and LRRK1. Our results reveal that LRRK2 is stabilized in solution by high pH buffers and that both LRRK2 and 
LRRK1 display similar, compact two-fold symmetric dimer structures with the particularity for LRRK2 that its 
N-terminal ARM domain extends outside of the dimer core. This work will further assist follow-up work towards 
high-resolution structures of these important molecules.
Materials and Methods
Protein expression and purification. Constructs. Constructs for the mammalian expression of 3xflag-
LRRK2 and 3xflag-LRRK1 included the pCHMWS-3xFLAG-LRRK2 and pCHMWS-3xFLAG-LRRK1 con-
structs, described previously16, 20, as well as the p3xFLAG-CMV-10-LRRK2 construct (a generous gift from Prof. 
Takeshi Iwatsubo) described in ref. 43.
Cell culture and transfection. HEK293FT cells (Life Technologies) were cultured in 15 cm Corning petri dishes 
(Sigma), at 37 °C in an atmosphere containing 5% CO2. The culture medium was comprised of Dulbecco’s 
Modified Eagle’s Medium (DMEM), 10% fetal bovine serum, 0.1 mM MEM nonessential amino acids (NEAA), 
2 mM L-glutamax and 1 mM MEM sodium pyruvate. One day prior to transfection, ~12.105 cells were plated 
out on a single 15 cm petri dish. The next day, cells were transfected with 30 μg of plasmid (3xFLAG-LRRK2 or 
3xFLAG-LRRK1) complexed with polyethyleneimine solution (PEI, 1 mg/ml, pH 7.0). To verify the efficacy of 
the transfection, a transfection with GFP plasmid was performed in parallel as a control. The proportion of cells 
transfected was monitored by fluorescence microscopy and the experiment was only continued for transfection 
rates greater than 50%.
Protein Purification. Protein purification was performed essentially as described previously4, 20. Forty-eight 
hours after transfection with the 3xFLAG-LRRK2 and 3xFLAG-LRRK1 constructs, the cells were rinsed with 
phosphate-buffered saline (PBS) and lysed in 1 mL lysis buffer (lysis buffer composition: 20 mM Tris/HCl, 
pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% (v/v) Triton X-100, 10% (v/v) glycerol and protease inhibitor cock-
tail (Sigma), or the optimal composition indicated by ProteoPlex, as detailed in the Results section), on ice, for 
10 min. The collected lysate was centrifuged at 4 °C for 10 min at 20,000 g to remove cell debris. The clear super-
natant was incubated overnight at 4 °C on a rotator mixer (STARLAB, Germany) with anti-Flag M2 agarose beads 
(Sigma-Aldrich) that had previously been equilibrated with lysis buffer. Afterwards, the beads were washed four 
times at 4 °C with wash buffer (25 mM Tris/HCl pH 7.5, 400 mM NaCl, 1% (v/v) Triton X-100 or the optimal lysis/
binding buffer indicated by ProteoPlex). Proteins prepared for testing in ProteoPlex assays were stored in storage 
buffer (i.e., 20 mM Tris/HCl pH 7.4, 200 mM NaCl, 5 mM MgCl2 1 mM DTT, 0.02% (v/v) Triton X-100, 50% 
(v/v) glycerol or the optimal lysis/binding buffer determined by the preceding ProteoPlex screen supplemented 
with 50% (v/v) glycerol) with 3xflag-LRRK2 still bound, at 4 °C until use. For EM analysis, the affinity-bound 
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3xflag-LRRK2 or 3xflag-LRRK1 protein was eluted by adding 5 volumes of elution buffer containing 100 μg/ml of 
3X FLAG® peptide (Sigma) and rotating the mixture on a wheel at 4 °C for 30 minutes (STARLAB, Germany). The 
composition of the elution buffer was 20 mM Tris/HCl pH 7.4, 200 mM NaCl, 5 mM MgCl2 1 mM DTT, 0.02% 
(v/v) Triton X-100, or the optimal composition indicated by ProteoPlex (see Results section). The beads were then 
spun down at 400 g for 2 minutes and supernatant containing the eluted protein was collected. EM-grids holding 
the purified protein were prepared straight away.
Radiometric nucleotide binding assay. To assess GDP/GTP binding capacity of purified 3xFLAG-LRRK1 and 
3xFLAG-LRRK2, affinity resin bound protein was prepared as described under protein purification, rinsed in 
guanine nucleotide binding buffer (Tris 25 mM pH 7.5, NaCl 150 mM, EDTA 5 mM, Triton 0.02%) and incu-
bated with radioactively labelled GTP (GTP-α-33P), in the presence or absence of 200 µM ‘cold’ nucleotides (GDP 
and GTP) at room temperature. Excess nucleotides were then removed by rinsing beads 3 times in nucleotide 
wash buffer (Tris 25 mM pH 7.5, MgCl2 10 mM, dithiothreitol (DTT) 2 mM, Triton 0.02%, beta-glycerophosphate 
5 mM, Na3VO4 0.1 mM). Bound GTP-α-33P was measured via scintillation counting and values of the different 
test conditions were normalized to the binding condition without cold nucleotides.
Buffer optimization by ProteoPlex screening. The ProteoPlex screening method based on the 
Thermofluor® differential scanning fluorimetry assay, was used to assess the stability of the multidomain 
3xflag-LRRK2 complexes in different buffer and additive systems. Conditions that resulted in thermal protein 
unfolding transitions closest to two state unfolding (i.e., unfolding from the native to the unfolded state, with-
out the formation of metastable intermediates) were considered optimal, as they indicate monodispersity and 
increased stability of macromolecular complexes29. It should be noted that the ProteoPlex assays were performed 
with protein in the absence of Triton X-100 as it interferes with the assay signal.
ProteoPlex assays of (i) 88 buffers and (ii) 88 buffer ligands/additives were performed in 96-well plates as 
given in ref. 29 to determine the optimal conditions for the stability of 3xflag-LRRK2 bound to the affinity beads 
(i.e., the optimum lysis/binding buffer). Flag-M2 agarose beads loaded with 3xflag-LRRK2 in storage buffer as 
described above (see above), were rinsed at 4 °C. The rinse buffer for (i), the buffer screen, was 20 mM Tris/HCl 
pH 7.4, 200 mM NaCl, 5 mM MgCl2, 1 mM DTT. The rinse buffer for (ii), the ligand/additive screen, was the same 
composition as (i) with the replacement of Tris by the optimal buffer determined from the buffer screen (Hepes 
pH 6.8, see Results section) at 4 °C, The rinsed beads were immediately aliquoted (16 µl aliquots) and tested by 
addition of 2 µl of ProteoPlex ×88 buffers (or ×88 ligands) screens at 4 °C. Then 2 µl SYPRO® Orange (Sigma 
Aldrich) was added to each aliquot and melting curves (i.e., state transition graphs) were recorded for each con-
dition to assess the stability of the bound protein.
To determine optimal buffer for eluting LRRK2 from affinity beads, flag-M2 agarose beads binding LRRK2 
were washed 3 times with 3 beads volumes of the optimal binding buffer (HEPES pH 6.8, 5 mM MgCl2, 100 mM 
NH4Cl, 5% (v/v) Ethylen Glycol and 10 mM CaCl2) and spun down over 1 minute at 4 °C and the supernatant 
discarded resulting in the same initial beads volume (600 µl). Aliquots (24×) were deposited in a transparent well 
plate and rinsed in the ProteoPlex assay buffers (sodium citrate, HEPES or Tris buffers with pHs ranging from 
5.5 to 9) finally leaving a 25 µl aliquot at 4 °C. 3xflag-LRRK2 protein was eluted at 4 °C by the addition of 1 µl 3X 
FLAG® peptide to each well (to 100 µg/ml). After 30 minutes the beads were sedimented using a table top centri-
fuge for 1 minute at 2500 rpm at 4 °C, and 18 µl of supernatant containing eluted 3xflag-LRRK2 protein were col-
lected. 2 µl of SYPRO® Orange dye was added to each supernatant following the ProteoPlex protocol and melting 
curves were recorded for each buffer condition. The curves were visually assessed, as the signals were too weak to 
carry out the standard ProteoPlex automated analysis described in ref. 29. Again, the buffer conditions displaying 
thermal unfolding transitions closest to a two state unfolding, that are known to be indicative of monodispersity 
and stability of macromolecular complexes29, were used to adapt the LRRK2 elution buffer, as indicated in the 
Results section.
Electron microscopy. For negative stain transmission electron microscopy (TEM), 3.5 µl of purified pro-
tein sample was pipetted onto a glow-discharged, carbon-coated copper grid and left to adsorb for 1 minute. The 
grid was then washed on three droplets of milliQ water, and subsequently stained on two droplets of 2% uranyl 
acetate (1 minute per drop), blotting between each step. Grids were scanned using a Philips CM10 TEM (FEI 
Company, Eindhoven, The Netherlands) operated at 80 kV under low-dose conditions (20 electrons/Å2). Images 
were collected at a nominal magnification of 96,000x with defocus values varying between −0.5 to −1.5 µm and 
recorded by a 2 K Veleta side-mounted TEM CCD camera (Olympus), corresponding to a pixel size of 3.8 Å at 
the specimen level.
For cryo-EM, 3.5 µl of purified protein sample was pipetted onto a glow-discharged, holey carbon film 
(Quantifoil R2/2, Quantifoil Micro Tools, Jena, Germany) with an additional thin layer of carbon, and left to 
adsorb for 1 minute. The grids were then rapidly plunge-frozen in liquid ethane cooled by liquid nitrogen, using 
a MarkIV Vitrobot (FEI, Eindhoven, Netherlands). The time between elution of purified LRRK2 or LRRK1 and 
cryo-EM grid preparation was kept to a minimum (60 minutes). The frozen grids were transferred to a Gatan-
626 cryo-holder. Micrographs were recorded under low-dose conditions (25 electrons/Å2) using a CM200 TEM 
(FEI Company, Eindhoven, The Netherlands) equipped with a TVIPS F416 CMOS camera (TVIPS, Gauting, 
Germany). The microscope was operated at 200 kV and a nominal magnification of 58,000x. The defocus ranged 
from −1 to −2.5 µm, corresponding to a pixel size of 2.7 Å at the specimen level.
Image processing. The EMAN2 software suite43 was initially used. Particles, i.e., images of single LRRK2 
or LRRK1 complexes, were extracted from the negative stain TEM or cryo-EM micrographs using the e2boxer 
interactive procedure. Contrast transfer function (CTF) correction was accomplished by producing high-pass 
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filtered and phase-flipped particles, using the e2ctf program. Reference-free class averages were generated using 
the e2refine2d program, requesting the generation of 128 classes with a maximum of 100 particles per class. The 
e2initialmodel utility was employed to generate initial models from the best 2D class averages (10 in all), without 
and with imposed C2 symmetry. The final 3D maps were refined using the standard iterative projection match-
ing, class-averaging and Fourier reconstruction procedure of EMAN2. The resolution of each reconstruction was 
determined by the gold standard Fourier shell correlation criterion. UCSF Chimera44 was employed to visualize 
and analyze the final maps.
In addition, the RELION software33 was employed to generate 2D class averages of the same particles and 
obtain a 3D model for comparison. After CTF correction in EMAN2, the newly incorporated e2refinetorelion2d 
EMAN2 functionality45 was used to export the particles to RELION and run 25 rounds of 2D reference-free class 
refinement with 128 classes in total, finishing with an angular sampling of 1.875 degrees translational sampling 
of 0.5 pixels. To generate an initial model in RELION, a 3D classification was performed with only one class 
and C1 symmetry, using a sphere as the initial reference and all the selected particles from the 2D classification. 
After 50 iterations, an initial consensus model with a spectral signal-to-noise ratio (SSNR) below 1.0 at 19.2 Å 
was obtained. Using this consensus model as reference, 3D classification was performed using four classes with 
C2 symmetry. Initially, 50 iterations were performed with a Tau factor of 3.6 and a sampling of, respectively, 7.5 
degrees and 1 pixel. Afterwards, an additional 25 steps were performed using an angular step of 1.9 degrees.
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